Drug
GS-3242 clinical trials
Also written GS-3242.
- studies test it
- 4
- open now
- 3
- in phase 3
- 1
- first study started
- 2025
Keep track of what changes. Save the GS-3242 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Studies by the year they started
4 studies that test it; most in 2026 (3)
| Year | Studies |
|---|---|
| 2025 | 1 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 3
- Phase 3
- 1
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Lenacapavir (3) · Bictegravir (2) · Emtricitabine (2) · Tenofovir alafenamide (2)
Studies
Open first, then newest update. How each study uses GS-3242 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Substudy-01: A Study of Long-Acting HIV-1 Treatments Taken by Mouth in People With HIV-1 With Undetectable Virus LevelsRecruitingPhase 2Gilead SciencesNCT07841990Written as GS-3242
- A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1RecruitingPhase 2Gilead SciencesNCT07645287Written as GS-3242 Tablet
- Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 TreatmentRecruitingPhase 2/3Gilead SciencesNCT07708727Written as GS-3242 Tablet
- Study of GS-3242 in Participants With HIV-1; Substudy-05CompletedPhase 1Gilead SciencesNCT07001319Written as GS-3242